Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C, Tyrer J, Coles CE, Haviland JS, Parker C, Gómez-Caamaño A, Calvo-Crespo P, Sosa-Fajardo P, Burnet NG, Summersgill H, Webb A, De Ruysscher D, Seibold P, Chang-Claude J, Talbot CJ, Rattay T, Parliament M, De Ruyck K, Rosenstein BS, Pharoah PDP, Dunning AM, Vega A, West CML; RGC and REQUITE Consortia. Barnett GC, et al. Among authors: de ruyck k, de ruysscher d. Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):494-501. doi: 10.1016/j.ijrobp.2022.06.098. Epub 2022 Jul 15. Int J Radiat Oncol Biol Phys. 2022. PMID: 35840111 Free article.
Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients.
Lutgens LC, Deutz N, Granzier-Peeters M, Beets-Tan R, De Ruysscher D, Gueulette J, Cleutjens J, Berger M, Wouters B, von Meyenfeldt M, Lambin P. Lutgens LC, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):275-85. doi: 10.1016/j.ijrobp.2004.02.052. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337566
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242
Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.
De Ruysscher D, Wanders S, van Haren E, Hochstenbag M, Geeraedts W, Utama I, Simons J, Dohmen J, Rhami A, Buell U, Thimister P, Snoep G, Boersma L, Verschueren T, van Baardwijk A, Minken A, Bentzen SM, Lambin P. De Ruysscher D, et al. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):988-94. doi: 10.1016/j.ijrobp.2004.12.019. Int J Radiat Oncol Biol Phys. 2005. PMID: 15989999 Clinical Trial.
Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study.
Bosmans G, van Baardwijk A, Dekker A, Ollers M, Boersma L, Minken A, Lambin P, De Ruysscher D. Bosmans G, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):748-53. doi: 10.1016/j.ijrobp.2006.05.022. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011450
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
De Ruysscher D, Dehing C, Bremer RH, Bentzen SM, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M, Dingemans AM, Boersma L, van Haren E, Geraedts W, Pitz C, Simons J, Wouters B, Rosier JF, Lambin P. De Ruysscher D, et al. Ann Oncol. 2007 May;18(5):909-16. doi: 10.1093/annonc/mdm005. Epub 2007 Feb 23. Ann Oncol. 2007. PMID: 17322546 Free article.
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
De Ruysscher D, Wanders R, van Haren E, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P. De Ruysscher D, et al. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. doi: 10.1016/j.ijrobp.2007.09.048. Epub 2007 Nov 26. Int J Radiat Oncol Biol Phys. 2008. PMID: 18037581 Clinical Trial.
Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study.
van Baardwijk A, Bosmans G, Boersma L, Wanders S, Dekker A, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1394-401. doi: 10.1016/j.ijrobp.2007.11.070. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258380
489 results